In experiments with human cells and mice, researchers report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.
from Latest Science News -- ScienceDaily https://ift.tt/39InHVY
via IFTTT
Monday, February 17, 2020
Combination drug therapy for childhood brain tumors shows promise in laboratory models
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment